Back to trial details

Intake questionnaire

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Applying to VA Palo Alto Health Care System · Palo Alto, California

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 50 and 80 years old?
2. Have you been diagnosed with Lung Cancer (Diagnosis)?
3. Are you able to travel to Palo Alto for study visits?